All Pharma News
BioMarin To Present VOXZOGO® Data At Children`s Bone Health Conference

BioMarin To Present VOXZOGO® Data At Children`s Bone Health Conference
PR NEWSWIRE
17 Jun 2024
Share Share
BioMarin: 4-Year ROCTAVIAN® Safety, Efficacy Data At Hemostasis Congress

BioMarin: 4-Year ROCTAVIAN® Safety, Efficacy Data At Hemostasis Congress
PR NEWSWIRE
07 Jun 2024
Share Share
BioMarin confirms layoffs and R&D cuts

BioMarin confirms layoffs and R&D cuts
LABPULSE
15 May 2024
Share Share
BioMarin sheds 170 jobs in wake of narrowed R&D refocus

BioMarin sheds 170 jobs in wake of narrowed R&D refocus
James Waldron FIERCE BIOTECH
15 May 2024
Share Share
BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV

BioMarin to Present at the BofA Securities 2024 Health Care Conference on Wednesday, May 15 at 10:00am PT / 1:00pm ET, in Las Vegas, NV
PRESS RELEASE
08 May 2024
Share Share
New Data for BioMarin`s VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting

New Data for BioMarin`s VOXZOGO® (vosoritide) for Multiple Growth-Related Conditions in Children Presented at Pediatric Endocrine Society (PES) Annual Meeting
PRESS RELEASE
04 May 2024
Share Share
BioMarin axes 4 candidates, centers R&D around 3 assets

BioMarin axes 4 candidates, centers R&D around 3 assets
Gabrielle Masson FIERCE BIOTECH
26 Apr 2024
Share Share
BioMarin shares fall on slight revenue miss, despite EPS beat

BioMarin shares fall on slight revenue miss, despite EPS beat
INVESTING
24 Apr 2024
Share Share
BioMarin`s Roctavian struggles continue. Is a divestment in the future?

BioMarin`s Roctavian struggles continue. Is a divestment in the future?
Nicole DeFeudis ENDPTS
24 Apr 2024
Share Share
BioMarin Reports Record Financial Results for the First Quarter 2024

BioMarin Reports Record Financial Results for the First Quarter 2024
PR NEWSWIRE
24 Apr 2024
Share Share